StonvexLoading…
StonvexStonvexStonvexCore line items from DUOT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.72M | $27.02M | $17.57M | $10.69M |
Operating Income | $-3.63M | $-9.76M | $-6.35M | $-5.23M |
Net Income | $-3.49M | $-9.84M | $-6.64M | $-5.60M |
EPS (Diluted) | $-0.15 | $-0.64 | $-0.49 | $-0.48 |
Total Assets | $122.92M | $63.41M | $69.79M | $31.13M |
Total Liabilities | $16.04M | $14.86M | $20.29M | $26.40M |
Cash & Equivalents | $33.03M | $15.47M | $33.20M | $1.47M |
Free Cash Flow OCF − CapEx | Not available | $-37.41M | $-18.85M | $-9.24M |
Shares Outstanding | 29.56M | 20.45M | 20.32M | 12.32M |